Russell Eugene Ching, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 2 carriers
- Offices
- 2
- Since medical school
- 47 years
- R Franklin University of Med & Sci/Chicago Medical School, 1979
Offices
2 locations · University of California San Francisco · Regents of the University of California
Hospitals listed: California Pacific Medical Center- Van Ness Campus · UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ching’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
12 of 12 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G43021 · Current
Licensed to practise in California · since 1980 · expires 2028-05-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$94,525
Medicare paid this office $94,525 for 667 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 199 | $31,303 | $123 |
| Return visit (30+ min) | 236 | $22,869 | $77 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 461 | $10,074 | $15 |
| New patient visit (60+ min) | 54 | $8,330 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 127 | $6,970 | $54 |
See all 9 services
| Long return visit (40+ min) | 199 | $31,303 | $123 |
| Return visit (30+ min) | 236 | $22,869 | $77 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 461 | $10,074 | $15 |
| New patient visit (60+ min) | 54 | $8,330 | $154 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 127 | $6,970 | $54 |
| New patient visit (45+ min) | 57 | $5,934 | $104 |
| Short return visit (20+ min) | 61 | $3,381 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 285 | $2,067 | $7 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,327 | $111 |
Who their Medicare patients are
667 Original Medicare patients in 2024. Average age 77 · Under 65 4% · 85 and older 19% · Women 49% · Also on Medicaid 31% · Health risk score 1.60. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 50% · Atrial fibrillation 40% · Diabetes 33% · Chronic kidney disease 29% · Heart failure 25% · Depression 19% · Cancer 17% · COPD 14% · Stroke 9% · Dementia 7%.
The office billed $651,454, Medicare allowed $128,128 and paid $94,525; for 1,922 services of 23 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 667 | 1,922 | 77 | 1.60 | $651,454 | $94,525 |
| 2023 | 669 | 1,279 | 77 | 1.61 | $655,190 | $92,751 |
| 2022 | 708 | 1,336 | 77 | 1.45 | $631,789 | $91,558 |
| 2021 | 573 | 1,187 | 77 | 1.61 | $587,243 | $87,810 |
| 2020 | 498 | 1,169 | 77 | 1.83 | $529,572 | $76,870 |
| 2019 | 524 | 1,245 | 76 | 1.81 | $526,454 | $72,082 |
| 2018 | 556 | 1,443 | 77 | 1.91 | $620,236 | $89,488 |
| 2017 | 446 | 1,122 | 77 | 1.65 | $466,098 | $63,665 |
| 2016 | 483 | 1,381 | 76 | 1.79 | $437,356 | $97,378 |
| 2015 | 736 | 1,905 | 76 | 2.08 | $391,966 | $124,521 |
| 2014 | 673 | 1,840 | 76 | 1.79 | $402,500 | $130,281 |
| 2013 | 702 | 1,722 | 76 | 1.99 | $434,976 | $94,711 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 231 | $37,093 | $116 |
| Return visit (30+ min) | 236 | $23,708 | $79 |
| New patient visit (60+ min) | 95 | $13,726 | $144 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 132 | $7,339 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 281 | $1,874 | $6 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,755 | $117 |
| New patient visit (45+ min) | 17 | $1,631 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,570 | $71 |
2022: 6 services
| Long return visit (40+ min) | 240 | $42,755 | $117 |
| Return visit (30+ min) | 178 | $16,358 | $74 |
| New patient visit (60+ min) | 85 | $12,982 | $153 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 179 | $10,736 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 345 | $2,654 | $7 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 16 | $1,146 | $72 |
2021: 8 services
| Long return visit (40+ min) | 180 | $31,609 | $123 |
| Return visit (30+ min) | 184 | $20,811 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 223 | $13,820 | $60 |
| New patient visit (60+ min) | 63 | $10,250 | $163 |
| New patient visit (45+ min) | 37 | $3,964 | $107 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 180 | $1,440 | $7 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,138 | $37 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 12 | $713 | $59 |
2020: 14 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $17,172 | $94 |
| Return visit (30+ min) | 132 | $11,924 | $65 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 115 | $8,122 | $67 |
| Long return visit (40+ min) | 92 | $7,785 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 111 | $6,914 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,381 | $183 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 36 | $3,282 | $89 |
| Telephone medical discussion with physician, 11-20 minutes | 54 | $3,102 | $44 |
| Short return visit (20+ min) | 52 | $2,639 | $46 |
| New patient visit (45+ min) | 26 | $2,474 | $95 |
| Hospital discharge day management, 30 minutes or less | 30 | $2,071 | $67 |
| New patient visit (30+ min) | 12 | $680 | $57 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 90 | $587 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $38 | $3 |
2019: 18 services
| Long return visit (40+ min) | 138 | $16,704 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 57 | $12,867 | $93 |
| Return visit (30+ min) | 130 | $10,166 | $64 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 90 | $5,351 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 72 | $4,816 | $67 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,721 | $181 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,606 | $90 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 33 | $2,077 | $63 |
| New patient visit (60+ min) | 11 | $1,656 | $151 |
| Short return visit (20+ min) | 41 | $1,606 | $36 |
| Hospital discharge day management, 30 minutes or less | 24 | $1,600 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 195 | $1,554 | $7 |
| New patient visit (45+ min) | 16 | $1,418 | $89 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $545 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $454 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $315 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $216 | $14 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $38 | $3 |
2018: 21 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $15,286 | $93 |
| Long return visit (40+ min) | 115 | $14,580 | $91 |
| Return visit (30+ min) | 165 | $14,504 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 112 | $7,263 | $64 |
| New patient visit (60+ min) | 41 | $5,754 | $140 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 84 | $5,603 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 39 | $3,585 | $87 |
| New patient visit (45+ min) | 30 | $3,309 | $110 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 18 | $3,241 | $180 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 46 | $2,789 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $2,134 | $65 |
| Short return visit (20+ min) | 27 | $1,353 | $44 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 175 | $1,301 | $7 |
| Hospital discharge day management, 30 minutes or less | 18 | $1,189 | $66 |
| Hospital discharge day management, more than 30 minutes | 11 | $1,073 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 33 | $636 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 33 | $427 | $13 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $358 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 20 | $280 | $13 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 25 | $165 | $7 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $37 | $3 |
2017: 14 services
| Return visit (30+ min) | 185 | $18,492 | $62 |
| Long return visit (40+ min) | 68 | $8,429 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 123 | $6,620 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 21 | $4,943 | $93 |
| New patient visit (45+ min) | 35 | $3,362 | $96 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 52 | $3,236 | $62 |
| New patient visit (60+ min) | 19 | $2,654 | $140 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 20 | $1,791 | $90 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 178 | $1,593 | $7 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,124 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,034 | $65 |
| Short return visit (20+ min) | 29 | $1,027 | $33 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 28 | $560 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 26 | $349 | $13 |
2016: 21 services
| Return visit (30+ min) | 200 | $28,123 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $9,255 | $220 |
| Return visit (30+ min) | 113 | $8,932 | $70 |
| New patient visit (45+ min) | 37 | $5,337 | $144 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $5,263 | $62 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 21 | $5,242 | $250 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 82 | $4,608 | $56 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $3,235 | $120 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 157 | $2,891 | $16 |
| Long return visit (40+ min) | 17 | $2,700 | $135 |
| Short return visit (20+ min) | 34 | $2,198 | $56 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $1,394 | $107 |
| New patient visit (45+ min) | 12 | $1,380 | $115 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 116 | $984 | $8 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 15 | $959 | $64 |
| Short return visit (20+ min) | 19 | $817 | $43 |
| Hospital discharge day management, 30 minutes or less | 11 | $783 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $551 | $34 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $279 | $20 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 18 | $233 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $37 | $3 |
2015: 20 services
| Return visit (30+ min) | 210 | $34,812 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 62 | $14,110 | $217 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $12,414 | $259 |
| New patient visit (45+ min) | 72 | $10,119 | $141 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 67 | $9,779 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $7,126 | $119 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 87 | $5,016 | $56 |
| Short return visit (20+ min) | 55 | $3,825 | $61 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 286 | $3,004 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 164 | $2,845 | $15 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,708 | $107 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 33 | $1,706 | $34 |
| Hospital discharge day management, 30 minutes or less | 25 | $1,630 | $65 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 21 | $1,327 | $63 |
| Programming of dual lead pacemaker system | 11 | $571 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 17 | $539 | $28 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 37 | $473 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 19 | $432 | $23 |
| Ultrasound of heart blood flow, valves and chambers | 15 | $100 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $65 | $3 |
2014: 21 services
| Return visit (30+ min) | 252 | $41,054 | $91 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 56 | $12,583 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 81 | $11,771 | $64 |
| New patient visit (45+ min) | 70 | $9,742 | $139 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 71 | $8,918 | $121 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 27 | $7,740 | $287 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 126 | $7,370 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 163 | $3,048 | $15 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 13 | $3,017 | $232 |
| Short return visit (20+ min) | 44 | $2,562 | $55 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,911 | $91 |
| Programming of dual lead pacemaker system | 19 | $1,731 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 159 | $1,624 | $8 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 31 | $1,603 | $35 |
| Initial hospital observation care per day, typically 50 minutes | 12 | $1,407 | $117 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,120 | $66 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 17 | $1,096 | $64 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 33 | $431 | $13 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $365 | $24 |
| Ultrasound of heart blood flow, valves and chambers | 19 | $127 | $6 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $89 | $3 |
2013: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 110 | $17,661 | $60 |
| Return visit (30+ min) | 142 | $16,388 | $94 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 112 | $12,851 | $114 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 161 | $8,544 | $53 |
| New patient visit (45+ min) | 57 | $7,959 | $140 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 83 | $5,157 | $32 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 29 | $4,955 | $171 |
| Short return visit (20+ min) | 51 | $3,366 | $60 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 11 | $2,582 | $235 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 276 | $2,277 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 114 | $2,074 | $16 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,011 | $87 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 26 | $451 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 30 | $351 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $170 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $51 | $3 |
Medicaid work
$4,599 in 2024
Medicaid paid $4,599 for 54 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 27 | $3,092 |
| Return visit (30+ min) | 14 | $1,325 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 13 | $182 |
| 2024 | 54 | 3 | 15 | $4,599 |
| 2023 | 91 | 2 | 22 | $3,368 |
| 2022 | 145 | 3 | 27 | $488 |
| 2021 | 79 | 2 | 14 | $210 |
| 2020 | 38 | 3 | 13 | $598 |
| 2019 | 31 | 1 | 17 | $0 |
| 2018 | 12 | 1 | 12 | $0 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 14 | $2,462 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 77 | $906 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 118 | $488 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $0 |
| Hospital outpatient clinic visit for assessment and management of a patient | 13 | $0 |
2021
| Hospital outpatient clinic visit for assessment and management of a patient | 53 | $114 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 26 | $95 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 12 | $518 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | $80 |
| Telehealth originating site facility fee | 12 | $0 |
2019
| Hospital outpatient clinic visit for assessment and management of a patient | 31 | $0 |
2018
| Hospital outpatient clinic visit for assessment and management of a patient | 12 | $0 |
Drugs they prescribed that Part D paid
$567,111
Pharmacies billed $567,111 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,506) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
2,019 generic and fewer than 11 brand-name prescriptions · $567,111 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 172 | $212,573 | $1,236 |
| Xarelto | 80 | $98,097 | $1,226 |
| Farxiga | 56 | $54,422 | $972 |
| Entresto | 26 | $43,375 | $1,668 |
| Jardiance | 29 | $27,044 | $933 |
See all 43 drugs
| Eliquis | 172 | $212,573 | $1,236 |
| Xarelto | 80 | $98,097 | $1,226 |
| Farxiga | 56 | $54,422 | $972 |
| Entresto | 26 | $43,375 | $1,668 |
| Jardiance | 29 | $27,044 | $933 |
| Nexletol | 17 | $20,642 | $1,214 |
| Multaq | 13 | $18,266 | $1,405 |
| Vascepa | 15 | $8,669 | $578 |
| Carvedilol Er | 13 | $7,010 | $539 |
| Livalo | 14 | $6,877 | $491 |
| Praluent | 11 | $5,479 | $498 |
| Benicar | 12 | $4,904 | $409 |
| Metoprolol | 290 | $4,373 | $15 |
| Atorvastatin | 305 | $3,346 | $11 |
| Ezetimibe | 109 | $3,151 | $29 |
| Diltiazem 24hr Er (Cd) | 74 | $2,216 | $30 |
| Carvedilol | 171 | $1,651 | $10 |
| Olmesartan Medoxomil | 78 | $1,593 | $20 |
| Amiodarone | 35 | $1,419 | $41 |
| Rosuvastatin | 60 | $1,359 | $23 |
| Nebivolol | 18 | $1,289 | $72 |
| Nitroglycerin | 29 | $1,009 | $35 |
| Irbesartan | 29 | $841 | $29 |
| Amlodipine Besylate | 123 | $810 | $7 |
| Telmisartan | 33 | $769 | $23 |
| Chlorthalidone | 57 | $701 | $12 |
| Valsartan | 36 | $610 | $17 |
| Isosorbide Dinitrate | 21 | $598 | $28 |
| Potassium Chloride | 22 | $567 | $26 |
| Lisinopril | 64 | $489 | $8 |
| Losartan | 37 | $411 | $11 |
| Furosemide | 31 | $319 | $10 |
| Isosorbide Mononitrate Er | 18 | $284 | $16 |
| Torsemide | 17 | $256 | $15 |
| Digoxin | 16 | $248 | $16 |
| Diltiazem | 16 | $244 | $15 |
| Terazosin | 16 | $242 | $15 |
| Metoprolol | 31 | $235 | $8 |
| Spironolactone | 44 | $192 | $4 |
| Doxazosin Mesylate | 14 | $165 | $12 |
| Clopidogrel | 20 | $157 | $8 |
| Hydrochlorothiazide | 21 | $108 | $5 |
| Ramipril | 11 | $19 | $2 |
Year by year
| 2024 | 2,506 | 450 | 0% (0) | None | $567,111 |
| 2023 | 2,442 | 414 | 0% (0) | 17% | $545,372 |
| 2022 | 2,209 | 396 | 0% (0) | None | $403,138 |
| 2021 | 2,416 | 381 | 0% (0) | 20% | $400,274 |
| 2020 | 2,041 | 319 | 0% (0) | None | $344,509 |
| 2019 | 1,974 | 324 | 0% (0) | 26% | $302,585 |
| 2018 | 1,900 | 315 | 0% (0) | 24% | $252,068 |
| 2017 | 1,990 | 284 | 0% (0) | None | $255,294 |
| 2016 | 1,999 | 280 | None | 28% | $245,698 |
| 2015 | 1,872 | 258 | 0% (0) | 31% | $211,485 |
| 2014 | 1,590 | 253 | 0% (0) | 32% | $153,620 |
| 2013 | 518 | 149 | 0% (0) | 30% | $26,116 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 37 drugs
| Eliquis | 132 | $173,558 | $1,315 |
| Xarelto | 92 | $125,268 | $1,362 |
| Entresto | 42 | $62,272 | $1,483 |
| Farxiga | 43 | $47,510 | $1,105 |
| Multaq | 13 | $12,082 | $929 |
| Praluent | 19 | $10,052 | $529 |
| Carvedilol Er | 11 | $6,845 | $622 |
| Metoprolol | 279 | $6,456 | $23 |
| Atorvastatin | 321 | $6,453 | $20 |
| Ezetimibe | 90 | $5,047 | $56 |
| Olmesartan Medoxomil | 75 | $3,172 | $42 |
| Diltiazem 24hr Er (Cd) | 73 | $2,772 | $38 |
| Carvedilol | 181 | $2,686 | $15 |
| Amiodarone | 32 | $2,474 | $77 |
| Amlodipine Besylate | 139 | $2,389 | $17 |
| Chlorthalidone | 55 | $2,110 | $38 |
| Rosuvastatin | 55 | $1,700 | $31 |
| Losartan | 59 | $1,606 | $27 |
| Irbesartan | 32 | $1,309 | $41 |
| Lisinopril | 83 | $1,302 | $16 |
| Nitroglycerin | 27 | $1,145 | $42 |
| Terazosin | 35 | $886 | $25 |
| Isosorbide Mononitrate Er | 27 | $780 | $29 |
| Valsartan | 20 | $749 | $37 |
| Telmisartan | 15 | $709 | $47 |
| Labetalol | 11 | $664 | $60 |
| Furosemide | 56 | $650 | $12 |
| Bumetanide | 11 | $626 | $57 |
| Potassium Chloride | 13 | $545 | $42 |
| Digoxin | 19 | $469 | $25 |
| Spironolactone | 41 | $402 | $10 |
| Metoprolol | 33 | $338 | $10 |
| Clonidine | 17 | $316 | $19 |
| Hydralazine | 14 | $295 | $21 |
| Clopidogrel | 13 | $246 | $19 |
| Hydrochlorothiazide | 26 | $213 | $8 |
| Pravastatin | 11 | $153 | $14 |
2022: 30 drugs
| Eliquis | 143 | $149,456 | $1,045 |
| Xarelto | 106 | $119,005 | $1,123 |
| Entresto | 28 | $39,271 | $1,403 |
| Ezetimibe | 68 | $6,229 | $92 |
| Metoprolol | 240 | $4,874 | $20 |
| Atorvastatin | 284 | $4,141 | $15 |
| Amiodarone | 31 | $4,096 | $132 |
| Olmesartan Medoxomil | 64 | $3,050 | $48 |
| Carvedilol | 176 | $2,356 | $13 |
| Rosuvastatin | 32 | $2,146 | $67 |
| Nitroglycerin | 32 | $2,075 | $65 |
| Irbesartan | 39 | $2,057 | $53 |
| Diltiazem 24hr Er (Cd) | 74 | $1,779 | $24 |
| Amlodipine Besylate | 175 | $1,744 | $10 |
| Chlorthalidone | 44 | $1,251 | $28 |
| Losartan | 66 | $999 | $15 |
| Isosorbide Mononitrate Er | 32 | $929 | $29 |
| Furosemide | 94 | $694 | $7 |
| Telmisartan | 12 | $681 | $57 |
| Lisinopril | 66 | $552 | $8 |
| Clopidogrel | 19 | $441 | $23 |
| Terazosin | 20 | $430 | $22 |
| Spironolactone | 25 | $379 | $15 |
| Metoprolol | 27 | $288 | $11 |
| Atenolol | 18 | $226 | $13 |
| Diltiazem | 16 | $195 | $12 |
| Hydrochlorothiazide | 22 | $182 | $8 |
| Pravastatin | 13 | $137 | $11 |
| Clonidine | 12 | $94 | $8 |
| Simvastatin | 11 | $72 | $7 |
2021: 35 drugs
| Eliquis | 146 | $128,821 | $882 |
| Xarelto | 123 | $120,347 | $978 |
| Entresto | 31 | $34,043 | $1,098 |
| Livalo | 16 | $10,025 | $627 |
| Carvedilol Er | 11 | $6,685 | $608 |
| Metoprolol | 284 | $5,673 | $20 |
| Atorvastatin | 241 | $3,784 | $16 |
| Irbesartan | 54 | $3,745 | $69 |
| Olmesartan Medoxomil | 70 | $3,468 | $50 |
| Nitroglycerin | 70 | $2,818 | $40 |
| Diltiazem 24hr Er (Cd) | 60 | $2,652 | $44 |
| Ezetimibe | 41 | $2,602 | $63 |
| Edarbyclor | 11 | $2,414 | $219 |
| Carvedilol | 202 | $2,378 | $12 |
| Amiodarone | 25 | $2,206 | $88 |
| Chlorthalidone | 60 | $2,179 | $36 |
| Amlodipine Besylate | 183 | $1,192 | $7 |
| Furosemide | 129 | $937 | $7 |
| Losartan | 77 | $882 | $11 |
| Telmisartan | 15 | $859 | $57 |
| Lisinopril | 76 | $655 | $9 |
| Rosuvastatin | 27 | $499 | $18 |
| Isosorbide Mononitrate Er | 40 | $495 | $12 |
| Clopidogrel | 34 | $464 | $14 |
| Irbesartan-Hydrochlorothiazide | 15 | $408 | $27 |
| Potassium Chloride | 11 | $299 | $27 |
| Atenolol | 31 | $270 | $9 |
| Spironolactone | 18 | $258 | $14 |
| Terazosin | 15 | $253 | $17 |
| Hydralazine | 12 | $241 | $20 |
| Benazepril | 23 | $205 | $9 |
| Metoprolol | 33 | $195 | $6 |
| Pravastatin | 11 | $194 | $18 |
| Hydrochlorothiazide | 17 | $173 | $10 |
| Simvastatin | 13 | $96 | $7 |
2020: 30 drugs
| Eliquis | 143 | $121,014 | $846 |
| Xarelto | 143 | $113,570 | $794 |
| Entresto | 34 | $28,672 | $843 |
| Carvedilol Er | 14 | $8,803 | $629 |
| Metoprolol | 261 | $5,505 | $21 |
| Ezetimibe | 22 | $3,051 | $139 |
| Nitroglycerin | 66 | $3,013 | $46 |
| Atorvastatin | 145 | $2,760 | $19 |
| Ranolazine Er | 20 | $2,380 | $119 |
| Irbesartan | 67 | $2,086 | $31 |
| Diltiazem 24hr Er (Cd) | 58 | $1,773 | $31 |
| Amiodarone | 20 | $1,650 | $83 |
| Carvedilol | 129 | $1,280 | $10 |
| Chlorthalidone | 33 | $1,060 | $32 |
| Valsartan | 12 | $1,018 | $85 |
| Olmesartan Medoxomil | 43 | $781 | $18 |
| Amlodipine Besylate | 130 | $701 | $5 |
| Rosuvastatin | 30 | $699 | $23 |
| Lisinopril | 62 | $660 | $11 |
| Losartan | 69 | $652 | $9 |
| Isosorbide Mononitrate Er | 51 | $601 | $12 |
| Hydralazine | 23 | $523 | $23 |
| Clopidogrel | 37 | $499 | $13 |
| Furosemide | 98 | $498 | $5 |
| Warfarin | 13 | $313 | $24 |
| Metoprolol | 35 | $233 | $7 |
| Potassium Chloride | 16 | $211 | $13 |
| Spironolactone | 16 | $169 | $11 |
| Atenolol | 22 | $134 | $6 |
| Benazepril | 16 | $55 | $3 |
2019: 34 drugs
| Eliquis | 135 | $93,990 | $696 |
| Xarelto | 117 | $85,348 | $729 |
| Entresto | 43 | $26,232 | $610 |
| Bystolic | 32 | $9,407 | $294 |
| Carvedilol Er | 13 | $7,056 | $543 |
| Metoprolol | 197 | $5,514 | $28 |
| Atorvastatin | 144 | $3,385 | $24 |
| Nitroglycerin | 52 | $2,603 | $50 |
| Diltiazem 24hr Er (Cd) | 39 | $2,225 | $57 |
| Irbesartan | 73 | $2,027 | $28 |
| Carvedilol | 171 | $1,679 | $10 |
| Olmesartan Medoxomil | 43 | $1,598 | $37 |
| Amiodarone | 31 | $1,493 | $48 |
| Rosuvastatin | 41 | $1,345 | $33 |
| Ezetimibe | 13 | $1,084 | $83 |
| Toprol Xl | 11 | $838 | $76 |
| Propafenone | 15 | $810 | $54 |
| Lisinopril | 75 | $760 | $10 |
| Cartia Xt | 20 | $707 | $35 |
| Chlorthalidone | 20 | $623 | $31 |
| Isosorbide Mononitrate Er | 51 | $597 | $12 |
| Furosemide | 98 | $580 | $6 |
| Amlodipine Besylate | 98 | $567 | $6 |
| Hydralazine | 25 | $434 | $17 |
| Losartan | 44 | $430 | $10 |
| Clopidogrel | 22 | $397 | $18 |
| Warfarin | 11 | $220 | $20 |
| Potassium Chloride | 17 | $197 | $12 |
| Metoprolol | 32 | $166 | $5 |
| Benazepril | 18 | $132 | $7 |
| Atenolol | 22 | $118 | $5 |
| Hydrochlorothiazide | 16 | $62 | $4 |
| Famotidine | 15 | $55 | $4 |
| Metformin | 12 | $42 | $4 |
2018: 35 drugs
| Eliquis | 130 | $83,590 | $643 |
| Xarelto | 90 | $59,748 | $664 |
| Entresto | 34 | $17,353 | $510 |
| Brilinta | 35 | $17,261 | $493 |
| Bystolic | 24 | $8,508 | $355 |
| Ranexa | 14 | $7,037 | $503 |
| Metoprolol | 197 | $5,691 | $29 |
| Atorvastatin | 196 | $4,250 | $22 |
| Rosuvastatin | 34 | $1,482 | $44 |
| Nitroglycerin | 27 | $1,398 | $52 |
| Carvedilol | 151 | $1,227 | $8 |
| Isosorbide Dinitrate | 17 | $1,208 | $71 |
| Chlorthalidone | 21 | $940 | $45 |
| Digox | 14 | $873 | $62 |
| Irbesartan | 47 | $859 | $18 |
| Diltiazem 24hr Er (Cd) | 20 | $715 | $36 |
| Cartia Xt | 34 | $693 | $20 |
| Amlodipine Besylate | 107 | $646 | $6 |
| Lisinopril | 83 | $582 | $7 |
| Clopidogrel | 30 | $581 | $19 |
| Valsartan | 20 | $552 | $28 |
| Potassium Chloride | 27 | $485 | $18 |
| Isosorbide Mononitrate Er | 17 | $477 | $28 |
| Betaxolol | 13 | $402 | $31 |
| Furosemide | 97 | $397 | $4 |
| Losartan | 44 | $383 | $9 |
| Amiodarone | 41 | $380 | $9 |
| Metoprolol | 47 | $271 | $6 |
| Pantoprazole | 11 | $249 | $23 |
| Warfarin | 15 | $215 | $14 |
| Simvastatin | 12 | $210 | $18 |
| Spironolactone | 13 | $115 | $9 |
| Atenolol | 20 | $104 | $5 |
| Verapamil Er | 12 | $83 | $7 |
| Benazepril | 14 | $52 | $4 |
2017: 40 drugs
| Eliquis | 142 | $73,516 | $518 |
| Xarelto | 115 | $72,254 | $628 |
| Entresto | 21 | $11,356 | $541 |
| Ranexa | 14 | $9,019 | $644 |
| Coreg Cr | 21 | $7,809 | $372 |
| Brilinta | 16 | $7,630 | $477 |
| Benicar | 23 | $6,351 | $276 |
| Propafenone Hcl Er | 11 | $4,623 | $420 |
| Metoprolol | 133 | $4,320 | $32 |
| Atorvastatin | 174 | $3,200 | $18 |
| Bystolic | 20 | $3,090 | $154 |
| Rosuvastatin | 43 | $2,993 | $70 |
| Valsartan | 67 | $2,169 | $32 |
| Amiodarone | 44 | $2,169 | $49 |
| Potassium Chloride | 42 | $1,359 | $32 |
| Carvedilol | 135 | $1,073 | $8 |
| Nitroglycerin | 21 | $965 | $46 |
| Eplerenone | 12 | $823 | $69 |
| Chlorthalidone | 22 | $814 | $37 |
| Isosorbide Dinitrate | 18 | $752 | $42 |
| Metoprolol | 72 | $733 | $10 |
| Diltiazem 24hr Er | 15 | $641 | $43 |
| Lisinopril | 81 | $635 | $8 |
| Clopidogrel | 37 | $628 | $17 |
| Furosemide | 132 | $534 | $4 |
| Cartia Xt | 37 | $528 | $14 |
| Taztia Xt | 12 | $523 | $44 |
| Amlodipine Besylate | 106 | $498 | $5 |
| Pravastatin | 23 | $447 | $19 |
| Propafenone | 13 | $435 | $33 |
| Warfarin | 20 | $267 | $13 |
| Losartan | 34 | $265 | $8 |
| Irbesartan | 12 | $237 | $20 |
| Pantoprazole | 18 | $236 | $13 |
| Spironolactone | 32 | $185 | $6 |
| Fludrocortisone Acetate | 12 | $158 | $13 |
| Clonidine | 19 | $120 | $6 |
| Simvastatin | 16 | $117 | $7 |
| Hydrochlorothiazide | 12 | $68 | $6 |
| Atenolol | 11 | $62 | $6 |
2016: 34 drugs
| Eliquis | 200 | $82,569 | $413 |
| Xarelto | 122 | $66,290 | $543 |
| Multaq | 12 | $10,953 | $913 |
| Crestor | 22 | $9,563 | $435 |
| Coreg Cr | 22 | $8,063 | $367 |
| Benicar | 16 | $4,203 | $263 |
| Metoprolol | 132 | $3,880 | $29 |
| Rosuvastatin | 21 | $2,757 | $131 |
| Atorvastatin | 106 | $2,573 | $24 |
| Valsartan | 64 | $1,892 | $30 |
| Diltiazem 24hr Er | 21 | $1,302 | $62 |
| Carvedilol | 154 | $1,167 | $8 |
| Amiodarone | 49 | $1,106 | $23 |
| Potassium Chloride | 30 | $965 | $32 |
| Propafenone | 30 | $887 | $30 |
| Clopidogrel | 41 | $880 | $21 |
| Amlodipine Besylate | 137 | $871 | $6 |
| Chlorthalidone | 23 | $778 | $34 |
| Lisinopril | 114 | $746 | $7 |
| Cartia Xt | 25 | $716 | $29 |
| Metoprolol | 68 | $604 | $9 |
| Metolazone | 16 | $583 | $36 |
| Pravastatin | 15 | $535 | $36 |
| Digox | 16 | $526 | $33 |
| Furosemide | 115 | $499 | $4 |
| Losartan | 57 | $445 | $8 |
| Warfarin | 23 | $327 | $14 |
| Pantoprazole | 18 | $324 | $18 |
| Isosorbide Mononitrate Er | 12 | $281 | $23 |
| Nifedipine Er | 14 | $241 | $17 |
| Spironolactone | 16 | $241 | $15 |
| Simvastatin | 21 | $191 | $9 |
| Ramipril | 19 | $163 | $9 |
| Atenolol | 16 | $28 | $2 |
2015: 32 drugs
| Xarelto | 176 | $74,407 | $423 |
| Eliquis | 147 | $56,292 | $383 |
| Crestor | 42 | $16,939 | $403 |
| Multaq | 13 | $9,254 | $712 |
| Coreg Cr | 16 | $5,052 | $316 |
| Metoprolol | 108 | $3,717 | $34 |
| Atorvastatin | 137 | $2,496 | $18 |
| Omega-3 Acid Ethyl Esters | 11 | $1,518 | $138 |
| Cartia Xt | 36 | $1,438 | $40 |
| Carvedilol | 193 | $1,394 | $7 |
| Digox | 29 | $916 | $32 |
| Valsartan | 25 | $685 | $27 |
| Amlodipine Besylate | 119 | $683 | $6 |
| Clopidogrel | 37 | $670 | $18 |
| Lisinopril | 99 | $631 | $6 |
| Propafenone | 21 | $612 | $29 |
| Potassium Chloride | 21 | $592 | $28 |
| Taztia Xt | 13 | $559 | $43 |
| Chlorthalidone | 12 | $474 | $40 |
| Losartan | 53 | $469 | $9 |
| Warfarin | 23 | $458 | $20 |
| Nitrostat | 13 | $439 | $34 |
| Amiodarone | 34 | $424 | $12 |
| Metolazone | 21 | $422 | $20 |
| Furosemide | 117 | $408 | $3 |
| Nitroglycerin Patch | 14 | $382 | $27 |
| Diltiazem 24hr Er | 12 | $364 | $30 |
| Isosorbide Mononitrate Er | 20 | $292 | $15 |
| Metoprolol | 53 | $283 | $5 |
| Spironolactone | 27 | $247 | $9 |
| Simvastatin | 30 | $233 | $8 |
| Ramipril | 11 | $79 | $7 |
2014: 26 drugs
| Xarelto | 179 | $65,456 | $366 |
| Eliquis | 60 | $20,009 | $333 |
| Crestor | 54 | $14,812 | $274 |
| Ranexa | 12 | $4,963 | $414 |
| Diovan | 12 | $3,591 | $299 |
| Metoprolol | 104 | $3,102 | $30 |
| Atorvastatin | 151 | $2,837 | $19 |
| Carvedilol | 197 | $2,098 | $11 |
| Clopidogrel | 38 | $1,047 | $28 |
| Digoxin | 15 | $926 | $62 |
| Propranolol Hcl Er | 11 | $713 | $65 |
| Diltiazem 24hr Er | 26 | $696 | $27 |
| Lisinopril | 100 | $620 | $6 |
| Losartan | 40 | $542 | $14 |
| Amlodipine Besylate | 79 | $527 | $7 |
| Cartia Xt | 15 | $498 | $33 |
| Amiodarone | 32 | $362 | $11 |
| Simvastatin | 34 | $355 | $10 |
| Spironolactone | 36 | $346 | $10 |
| Furosemide | 83 | $338 | $4 |
| Spironolactone-Hctz | 11 | $300 | $27 |
| Nitrostat | 12 | $276 | $23 |
| Chlorthalidone | 12 | $253 | $21 |
| Warfarin | 15 | $248 | $17 |
| Hydrochlorothiazide | 12 | $97 | $8 |
| Metoprolol | 17 | $65 | $4 |
2013: 16 drugs
| Xarelto | 15 | $5,052 | $337 |
| Crestor | 17 | $2,987 | $176 |
| Diovan | 11 | $2,865 | $260 |
| Metoprolol | 51 | $1,773 | $35 |
| Atorvastatin | 33 | $1,198 | $36 |
| Lovaza | 11 | $1,139 | $104 |
| Carvedilol | 59 | $848 | $14 |
| Hydralazine | 13 | $591 | $45 |
| Lisinopril | 50 | $359 | $7 |
| Amiodarone | 18 | $353 | $20 |
| Diltiazem 24hr Er | 11 | $347 | $32 |
| Nitrostat | 11 | $296 | $27 |
| Potassium Chloride | 11 | $291 | $26 |
| Diltiazem Er | 13 | $228 | $18 |
| Amlodipine Besylate | 24 | $223 | $9 |
| Furosemide | 35 | $155 | $4 |
Money from drug and device companies
$239 in 2025
| 2025 | 2 | 2 | None | $239 |
| 2024 | 2 | 2 | None | $272 |
| 2023 | 2 | 3 | None | $399 |
| 2022 | 3 | 3 | None | $303 |
| 2021 | 3 | 4 | None | $292 |
| 2020 | 7 | 17 | None | $392 |
| 2019 | 16 | 46 | None | $1,560 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Repatha | $121 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $118 | 1 payment
|
See all 2 published payments
| Amgen | Meals · 2025-08-04 | Repatha | $121 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-12 | None | $118 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $272
| Amgen | Repatha | $150 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $121 | 1 payment
|
2023: $399
| Impulse Dynamics (USA) | Optimizer | $281 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $118 | 1 payment
|
2022: $303
| Abiomed | Impella | $111 | 1 payment
|
| Actelion Pharmaceuticals US | Uptravi | $109 | 1 payment
|
| Abbott Laboratories | Cardiomems | $82 | 1 payment
|
2021: $292
| La Jolla Pharmaceutical | Giapreza | $248 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $25 | 1 payment
|
| iRhythm Technologies | Zio Patch | $20 | 1 payment
|
2020: $392
| Janssen Pharmaceuticals | Xarelto | $222 | 9 payments
|
| Amgen | Repatha | $55 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $32 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $22 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $22 | 1 payment
|
| Astellas Pharma US | Lexiscan | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
2019: $1,560
| Amgen | Repatha | $237 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $193 | 7 payments
|
| Novartis Pharmaceuticals | Entresto | $184 | 6 payments
|
| Abbott Laboratories | Quadra Assura Crt Defibrillator | $159 | 1 payment
|
| Sanofi-Aventis U.S. | Praluent | $156 | 3 payments
|
| Actelion Pharmaceuticals US | Opsumit | $128 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $109 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $73 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $71 | 4 payments
|
| Janssen Scientific Affairs | Xarelto | $62 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $57 | 2 payments
|
| Lundbeck | Northera | $43 | 2 payments
|
| Boston Scientific | Watchman | $35 | 2 payments
|
| Gilead Sciences | None | $23 | 1 payment
|
| HeartFlow | None | $17 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1477504330
- Licence
- CA G43021California G43021: Current · expires 2028-05-31
- Trained
- R Franklin University of Med & Sci/Chicago Medical School, 1979 · 47 years ago
- Group
- University of California San Francisco · Regents of the University of California
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G430210
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 1 Daniel Burnham Ct Ste 260c, San Francisco, CA, 94109
- NPI first listed
- 2006-05-15
- NPI last updated
- 2021-10-05
- NPI record certified
- 2021-10-05
This is when the NPI record was last certified, not a medical board exam.